Guggenheim Capital LLC Fulgent Genetics, Inc. Transaction History

Guggenheim Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$29.39 - $36.27 $290,872 - $358,964	9,897 New	9,897 $308,000
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $203,579 - $266,248	4,243 Added 89.76%	8,970 $489,000
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $2,542 - $4,901	51 Added 1.09%	4,727 $295,000
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $150,348 - $204,225	-1,945 Reduced 29.38%	4,676 $470,000
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $427,283 - $632,735	-5,707 Reduced 46.29%	6,621 $596,000
Q2 2021 Aug 13, 2021	SELL	$66.8 - $100.45 $47,695 - $71,721	-714 Reduced 5.47%	12,328 $1.14 Million
Q1 2021 May 13, 2021	SELL	$59.3 - $183.85 $725,713 - $2.25 Million	-12,238 Reduced 48.41%	13,042 $1.26 Million
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $783,932 - $1.32 Million	25,280 New	25,280 $1.32 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.